Ebrahim Versi

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ David J. Marguglio, as Attorney-in-Fact for Ebrahim Versi
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ebrahim Versi

Form 4 holding CEO, Director

DMK PHARMACEUTICALS Corp

Security class
Common Stock
Shares / value
906,394
Estimated value
$547,099
Report date
15 Sep 2023
Price
$0.6036
Ownership
By Versi Group LLC
Form 4 holding CEO, Director

DMK PHARMACEUTICALS Corp

Security class
Common Stock
Shares / value
8,745
Estimated value
$5,278
Report date
15 Sep 2023
Price
$0.6036
Ownership
Direct
Form 4 holding CEO, Director

DMK PHARMACEUTICALS Corp

Security class
Series E Convertible Preferred Stock
Shares / value
1,212
Estimated value
Report date
15 Sep 2023
Price
Ownership
By Versi Group LLC
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Ebrahim Versi

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .